Drugs / SCH 39304
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00000677 | — | Cryptococcal meningitis, HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCH 39304 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000677 ↗ |
| Route | Oral | “SCH 39304 is administered orally once daily for 3 days” NCT00000677 ↗ |